These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8212321)
81. WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex. Millan MJ; Brocco M; Veiga S; Cistarelli L; Melon C; Gobert A Eur J Pharmacol; 1998 Jan; 341(2-3):165-7. PubMed ID: 9543235 [TBL] [Abstract][Full Text] [Related]
82. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency. Bergqvist PB; Wikell C; Hjorth S; Apelqvist G; Bengtsson F Clin Neuropharmacol; 1997 Dec; 20(6):511-22. PubMed ID: 9403225 [TBL] [Abstract][Full Text] [Related]
83. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296 [TBL] [Abstract][Full Text] [Related]
84. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Baumann MH; Ayestas MA; Dersch CM; Rothman RB Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249 [TBL] [Abstract][Full Text] [Related]
85. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor. Xue R; Jin ZL; Chen HX; Yuan L; He XH; Zhang YP; Meng YG; Xu JP; Zheng JQ; Zhong BH; Li YF; Zhang YZ Eur Neuropsychopharmacol; 2013 Jul; 23(7):728-41. PubMed ID: 22748419 [TBL] [Abstract][Full Text] [Related]
86. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test. Gigliucci V; Buckley KN; Nunan J; O'Shea K; Harkin A Pharmacol Biochem Behav; 2010 Feb; 94(4):524-33. PubMed ID: 19945477 [TBL] [Abstract][Full Text] [Related]
87. Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Ichikawa J; Meltzer HY Eur J Pharmacol; 1995 Aug; 281(3):255-61. PubMed ID: 8521908 [TBL] [Abstract][Full Text] [Related]
88. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization. Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239 [TBL] [Abstract][Full Text] [Related]
89. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Sánchez C; Hyttel J Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421 [TBL] [Abstract][Full Text] [Related]
91. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs. Lucki I; O'Leary OF J Clin Psychiatry; 2004; 65 Suppl 4():11-24. PubMed ID: 15046537 [TBL] [Abstract][Full Text] [Related]
92. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters. Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177 [TBL] [Abstract][Full Text] [Related]
93. Chronic treatment with antidepressants, verapamil, or lithium inhibits the serotonin-induced intracellular calcium response in individual C6 rat glioma cells. Yamaji T; Kagaya A; Uchitomi Y; Yokota N; Yamawaki S Life Sci; 1997; 60(11):817-23. PubMed ID: 9076320 [TBL] [Abstract][Full Text] [Related]
94. Effect of antidepressant and neuroleptic drugs on the electrically evoked release of serotonin from rat cerebral cortex. Gross G; Hante K; Göthert M Psychopharmacology (Berl); 1987; 91(2):175-81. PubMed ID: 2883696 [TBL] [Abstract][Full Text] [Related]
95. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935. Gobert A; Rivet JM; Cistarelli L; Millan MJ J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762 [TBL] [Abstract][Full Text] [Related]
96. Serotonin and Antidepressant SSRIs Inhibit Rat Neuroendocrine Dopamine Neurons: Parallel Actions in the Lactotrophic Axis. Lyons DJ; Ammari R; Hellysaz A; Broberger C J Neurosci; 2016 Jul; 36(28):7392-406. PubMed ID: 27413150 [TBL] [Abstract][Full Text] [Related]
97. Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex. Kamińska K; Gołembiowska K; Rogóż Z Pharmacol Rep; 2013; 65(5):1144-51. PubMed ID: 24399710 [TBL] [Abstract][Full Text] [Related]
99. Perinatal antidepressant exposure alters cortical network function in rodents. Simpson KL; Weaver KJ; de Villers-Sidani E; Lu JY; Cai Z; Pang Y; Rodriguez-Porcel F; Paul IA; Merzenich M; Lin RC Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18465-70. PubMed ID: 22025710 [TBL] [Abstract][Full Text] [Related]